NORD
June 24, 2019
Alnylam Honored by NORD with a Rare Impact Award
Alnylam Honored by NORD with a Rare Impact Award for the development and approval of ONPATTRO (patisiran).
Read More ›
June 24, 2019
Alnylam Honored by NORD with a Rare Impact Award
Alnylam Honored by NORD with a Rare Impact Award for the development and approval of ONPATTRO (patisiran).
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site